March 22, 2022
by Andrii Buvailo
Interview
Sponsored by PharmCADD
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years …
Feb. 22, 2022
by Andrii Buvailo
Interview
Researchers are looking to capitalize on the abundance of new types of data and higher resolution data to drive innovation. …
Feb. 18, 2022
by Andrii Buvailo
Biopharma insight
The global artificial intelligence (AI) leader Insilico Medicine announced its first milestone in cancer immunotherapy for their external collaboration with …
Feb. 14, 2022
by Chris De Savi
Biopharma insight
Drug Discovery crystal ball gazing for the year ahead. And the hottest prospects are discussed below. We already have 5 …
Feb. 4, 2022
by Alan Nafiiev
Biopharma insight
The BRD4 (Bromodomain-containing protein 4) protein is a transcriptional factor that plays an important role in cancer development. It has …
Jan. 26, 2022
by Andrii Buvailo
Biopharma insight
Artificial Intelligence (AI) in drug discovery is now on a steep rise. A growing number of companies compete to develop …
Jan. 24, 2022
by Chris De Savi
Biopharma insight
Antimicrobial resistance (AMR) poses a major threat to human health. There were an estimated 4.95M deaths associated with bacterial AMR …
Jan. 21, 2022
by Andrii Buvailo
Biopharma insight
In November 2021, the parent company of Google, Alphabet, Inc., announced the launch of a new commercial subsidiary in the …
Jan. 19, 2022
by Alan Nafiiev
Biopharma insight
Over the last five or so years, the drug discovery industry has started adopting artificial intelligence (AI) at unprecedented scale, …
Jan. 3, 2022
by Andrii Buvailo
Biopharma insight
Deep Knowledge Group, a UK-based consortium of commercial and non-for-profit companies in the domain of longevity industry and deep tech …
Dec. 7, 2021
by Chris De Savi
Biopharma insight
It has been a momentous year of innovation for drug discovery while the world is still facing the deadliest pandemic in …
Dec. 3, 2021
by Andrii Buvailo
Biopharma insight
Getting a step closer to treating Idiopathic Pulmonary Fibrosis A Hong Kong-based company applying a state-of-the-art artificial intelligence (AI) platform …